STOCK TITAN

Alto Ingredients, Inc. Reports First Quarter 2026 Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Alto Ingredients (NASDAQ: ALTO) reported Q1 2026 results for the quarter ended March 31, 2026. Net sales were $224.7 million and gross profit was $9.2 million versus a gross loss of $1.8 million a year earlier. Net income was $4.0 million, or $0.05 per diluted share, and Adjusted EBITDA was $4.7 million. Results reflected an $8.1 million unrealized derivative gain and contributions from Section 45Z tax credits. Cash totaled $20.3 million and borrowing availability was $94.3 million at quarter end. Management reiterated priorities on utilization, 2026 optimization projects and monetizing biogenic CO2 value.

Loading...
Loading translation...

Positive

  • Net income of $4.0 million (vs loss of $12.0M prior year)
  • Adjusted EBITDA of $4.7 million (improvement of $9.1M)
  • Gross profit of $9.2 million (vs gross loss of $1.8M)
  • Borrowing availability of $94.3 million

Negative

  • Cash decreased to $20.3 million from $23.4 million
  • Net sales slightly declined to $224.7 million from $226.5 million
  • Results included an $8.1 million unrealized derivatives gain
  • Earnings benefited from Section 45Z tax credits, indicating tax-credit dependence

Key Figures

Net sales: $224.7M Gross profit: $9.2M Net income: $4.0M +5 more
8 metrics
Net sales $224.7M Q1 2026, vs $226.5M in Q1 2025
Gross profit $9.2M Q1 2026, vs $1.8M gross loss in Q1 2025
Net income $4.0M Q1 2026, vs $12.0M net loss in Q1 2025
EPS (diluted) $0.05 Q1 2026, vs -$0.16 per share in Q1 2025
Adjusted EBITDA $4.7M Q1 2026, vs -$4.4M in Q1 2025
Unrealized derivative gain $8.1M Net unrealized gain boosting Q1 2026 gross profit
Cash & equivalents $20.3M Balance at March 31, 2026
Borrowing availability $94.3M At March 31, 2026 (line of credit and term loan facility)

Market Reality Check

Price: $5.99 Vol: Volume 2,702,719 is 1.87x...
high vol
$5.99 Last Close
Volume Volume 2,702,719 is 1.87x the 20-day average of 1,441,764, indicating elevated trading interest pre-news. high
Technical Price at $5.99 is trading above the 200-day MA of $2.46, reflecting a strong pre-news uptrend.

Peers on Argus

ALTO gained 9.51% while close peers were mixed: TSE -7.63%, FEAM +5.92%, LOOP -0...
2 Up 1 Down

ALTO gained 9.51% while close peers were mixed: TSE -7.63%, FEAM +5.92%, LOOP -0.72%, AMTX +1.67%, NTIC +0.63%. This pattern points to a stock-specific reaction rather than a broad specialty chemicals move.

Previous Earnings Reports

5 past events · Latest: Nov 05 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Nov 05 Q3 2025 earnings Positive +22.4% Improved segment performance with higher exports and CO2 demand driving profits.
Aug 06 Q2 2025 earnings Negative -3.9% Net sales decline and widened net loss versus prior-year quarter.
May 07 Q1 2025 earnings Negative -1.6% Net loss and negative Adjusted EBITDA despite operational initiatives.
Nov 06 Q3 2024 earnings Negative -37.6% Lower net sales and continued losses despite improved gross profit.
Aug 06 Q2 2024 earnings Negative +5.8% Revenue decline and swing to net loss but shares rose post-release.
Pattern Detected

Earnings releases have typically seen the stock move in the same direction as the fundamental tone, with one notable divergence when shares rose despite weaker results.

Recent Company History

Over the last several earnings cycles, Alto reported mixed but generally improving fundamentals. Q2 and Q3 2024 showed declining sales and losses, yet Q2 had a positive share reaction. Through 2025, Q2 remained loss-making while Q3 results highlighted broad improvement and drove a strong double-digit gain. Q1 2025 still carried losses despite operational progress. The latest Q1 2026 release continues this trajectory by returning to profitability, supported by higher crush margins, exports, and Section 45Z tax credits.

Historical Comparison

-3.0% avg move · Over the past five earnings releases, ALTO’s average move was -2.97%. Today’s +9.51% reaction to a r...
earnings
-3.0%
Average Historical Move earnings

Over the past five earnings releases, ALTO’s average move was -2.97%. Today’s +9.51% reaction to a return to quarterly profitability stands as a notably stronger response than typical.

Across recent earnings, Alto moved from recurring losses toward improved profitability, aided by portfolio realignment, export renewable fuels, CO₂ utilization and Section 45Z tax credits, with Q1 2026 now showing positive net income and Adjusted EBITDA.

Market Pulse Summary

This announcement highlights Alto’s return to profitability in Q1 2026, with net income of $4.0M, Ad...
Analysis

This announcement highlights Alto’s return to profitability in Q1 2026, with net income of $4.0M, Adjusted EBITDA of $4.7M, and gross profit of $9.2M aided by an $8.1M unrealized derivative gain and Section 45Z tax credits. Liquidity included $20.3M in cash and $94.3M of borrowing availability. Compared with prior periods of net losses, the update underscores progress in operational realignment and tax-credit monetization. Investors may watch future quarters for consistency in margins and earnings without derivative or credit boosts.

Key Terms

adjusted ebitda, derivatives, non-gaap, gaap
4 terms
adjusted ebitda financial
"Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
derivatives financial
"Gross profit was positively impacted by an $8.1 million net unrealized gain on derivatives."
Derivatives are financial contracts whose value depends on the price or performance of another asset, such as a stock, bond, commodity, currency or interest rate. Investors use them to hedge against risk, to speculate on future price moves, or to gain exposure without owning the asset — like buying insurance or placing a leveraged bet — so they can both protect portfolios and magnify gains or losses, affecting risk and market liquidity.
non-gaap financial
"Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
gaap financial
"measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures"
GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.

AI-generated analysis. Not financial advice.

Q1 2026 Gross Profit of $9.2 Million Increased $11.0 Million
Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million
Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025

PEKIN, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026.

“In a seasonally weak period for Alto and the industry, we delivered profitability on an adjusted EBITDA and net income basis through the contributions of strong export sales, higher crush margins and incremental earnings from Section 45Z tax credits. Even without the contribution of the tax credits we were profitable,” said President and Chief Executive Officer Bryon McGregor. “Our strategic realignment, combined with our efforts to improve our operational model and the stability of our business have enhanced our earnings power.”

Added Mr. McGregor, “Looking ahead, our priorities are straightforward: improve utilization and reliability; execute our 2026 optimization and capital projects on time and on budget; and leverage the flexibility we have with multiple revenue streams to respond to market shifts and perform profitably through commodity cycles. In addition, we are focused on expanding the value we capture from 45Z tax credits and on optimally monetizing the value of our biogenic CO2 production across our facilities to lower our carbon footprint. Through our focus on these priorities, we remain committed to enhancing the value of our assets.”

Financial Results for the Three Months Ended March 31, 2026 Compared to 2025

  • Net sales were $224.7 million, compared to $226.5 million.
  • Cost of goods sold was $215.5 million, compared to $228.3 million.
  • Gross profit was $9.2 million, compared to a gross loss of $1.8 million. Gross profit was positively impacted by an $8.1 million net unrealized gain on derivatives.
  • Selling, general and administrative expenses were $6.7 million, compared to $7.2 million.
  • Interest expense was $2.2 million, compared to $2.7 million.
  • Net income attributable to common stockholders was $4.0 million, or $0.05 per diluted share, compared to a net loss of $12.0 million, or $0.16 per share.
  • Adjusted EBITDA was $4.7 million, compared to negative $4.4 million, an increase of $9.1 million.

Cash and cash equivalents at March 31, 2026 were $20.3 million, compared to $23.4 million at December 31, 2025. The company’s borrowing availability at March 31, 2026 was $94.3 million, including $29.3 million under the company’s operating line of credit and $65 million under its term loan facility.

First Quarter 2026 Results Conference Call
Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, May 6, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

Use of Non-GAAP Measures
Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

About Alto Ingredients, Inc.
Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations around profitability and executing on opportunities to grow earnings, including through improved utilization and reliability, optimization and capital projects, monetizing additional Section 45Z tax credits and monetizing the value of its biogenic CO2 to lower its carbon footprint; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; Alto Ingredients’ ability to timely and within budget execute on its optimization and capital projects; Alto Ingredients’ ability to expand and monetize the value of its CO2 production to lower its carbon footprint; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2026.

Company IR and Media Contact:
Michael Kramer, Alto Ingredients, Inc., 916-403-2755
Investorrelations@altoingredients.com

IR Agency Contact:
Jody Burfening, Alliance Advisors Investor Relations, 212-838-3777
Investorrelations@altoingredients.com


ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)
  
 Three Months Ended
March 31,
  2026  2025 
Net sales$224,680 $226,540 
Cost of goods sold 215,461  228,347 
Gross profit (loss) 9,219  (1,807)
Selling, general and administrative expenses 6,699  7,190 
Income (loss) from operations 2,520  (8,997)
Interest expense, net (2,198) (2,729)
Transferable tax credits, net 3,900   
Other income, net 49  47 
Income (loss) before provision for income taxes 4,271  (11,679)
Provision for income taxes    
Net income (loss)$4,271 $(11,679)
Preferred stock dividends$(312)$(312)
Net income (loss) attributable to common stockholders$3,959 $(11,991)
Net income (loss) per share, basic$0.05 $(0.16)
Net income (loss) per share, diluted$0.05 $(0.16)
Weighted-average shares outstanding, basic 74,789  73,836 
Weighted-average shares outstanding, diluted 76,639  73,836 



ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value) 
       

ASSETS
 March 31,
2026
  December 31,
2025
 
Current Assets:      
Cash and cash equivalents$20,309 $23,415 
Restricted cash 1,334  2,258 
Accounts receivable, net 59,700  55,069 
Inventories 52,831  61,676 
Derivative instruments 7,831  525 
Transferable tax credits, net 11,530  7,500 
Other current assets 5,017  5,474 
Total current assets 158,552  155,917 
Property and equipment, net 193,199  198,501 
Other Assets:     
Right of use operating lease assets, net 17,215  16,931 
Intangible assets, net 7,419  7,574 
Other assets 9,908  9,863 
Total other assets 34,542  34,368 
Total Assets$386,293 $388,786 



ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)
       

LIABILITIES AND STOCKHOLDERS’ EQUITY
 March 31,
2026
  December 31,
2025
 
Current Liabilities:     
Accounts payable$19,303 $14,509 
Accrued liabilities 12,332  16,691 
Current portion – long-term debt   16,600 
Current portion – operating leases 4,975  4,958 
Derivative instruments 301  1,067 
Other current liabilities 4,741  5,246 
Total current liabilities 41,652  59,071 
       
Long-term debt 73,056  63,027 
Operating leases, net of current portion 13,240  13,012 
Other liabilities 8,467  8,435 
Total Liabilities 136,415  143,545 
       
Stockholders’ Equity:      
Preferred stock, $0.001 par value; 10,000 shares authorized;
   Series A: no shares issued and outstanding as of
   March 31, 2026 and December 31, 2025
   Series B: 927 shares issued and outstanding as of
   March 31, 2026 and December 31, 2025
 1  1 
Common stock, $0.001 par value; 300,000 shares
   authorized; 77,946 and 77,307 shares issued and
   outstanding as of March 31, 2026 and December 31,
   2025, respectively
 78  77 
Non-voting common stock, $0.001 par value; 3,553
   shares authorized; 1 share issued and outstanding as
   of March 31, 2026 and December 31, 2025
    
Additional paid-in capital 1,052,472  1,051,795 
Accumulated other comprehensive income 5,461  5,461 
Accumulated deficit (808,134) (812,093)
Total Stockholders’ Equity 249,878  245,241 
Total Liabilities and Stockholders’ Equity$386,293 $388,786 


Reconciliation of Adjusted EBITDA to Net Income (Loss)

 Three Months Ended
March 31,
(in thousands) (unaudited) 2026  2025 
Net income (loss)$4,271 $(11,679)
Adjustments:  
Interest expense 2,198  2,729 
Interest income (77) (84)
Unrealized derivatives gains (8,073) (1,634)
Depreciation and amortization expense 6,366  6,266 
Total adjustments 414  7,277 
Adjusted EBITDA$4,685 $(4,402)


Segment Financials

(in thousands) (unaudited)Three Months Ended
March 31,
  2026  2025 
Net sales      
       
Pekin Campus production:      
Alcohol sales$107,952 $107,234 
Essential ingredient sales 43,993  44,618 
Intersegment sales 262  297 
Total Pekin Campus sales 152,207  152,149 
       
Marketing and distribution:      
Alcohol sales$47,326 $49,058 
Intersegment sales 2,450  2,506 
Total marketing and distribution sales 49,776  51,564 
       
Western production:      
Alcohol sales$16,680 $16,194 
Essential ingredient sales 7,280  7,808 
Intersegment sales 399  264 
Total Western production sales 24,359  24,266 
       
Corporate and other 1,449  1,628 
Intersegment eliminations (3,111) (3,067)
Net sales as reported$224,680 $226,540 
       
Cost of goods sold:    
Pekin Campus production$144,021 $155,222 
Marketing and distribution 46,037  47,650 
Western production 25,502  25,524 
Corporate and other 1,036  1,681 
Intersegment eliminations (1,135) (1,730)
Cost of goods sold as reported$215,461 $228,347 
       
Gross profit (loss):      
Pekin Campus production$8,186 $(3,073)
Marketing and distribution 3,739  3,914 
Western production (1,143) (1,258)
Corporate and other 413  (53)
Intersegment eliminations (1,976) (1,337)
Gross profit (loss) as reported$9,219 $(1,807)


Sales and Operating Metrics (unaudited)

(in thousands) (unaudited)Three Months Ended
March 31,
  2026  2025 
Alcohol Sales (gallons in millions)    
Pekin Campus renewable fuel gallons sold 31.2  32.6 
Western production renewable fuel gallons sold 8.2  8.3 
Third party renewable fuel gallons sold 23.5  24.4 
Total renewable fuel gallons sold 62.9  65.3 
Specialty alcohol gallons sold 23.0  24.3 
Total gallons sold 85.9  89.6 
     
Sales Price per Gallon    
Pekin Campus$2.00 $1.90 
Western production$2.03 $1.95 
Marketing and distribution$2.01 $2.01 
Average sales price per gallon$2.00 $1.93 
     
Alcohol Production (gallons in millions)    
Pekin Campus 51.2  54.3 
Western production 7.9  8.3 
Total 59.1  62.6 
     
Corn Cost per Bushel    
Pekin Campus$4.45 $4.65 
Western production$5.54 $5.95 
Total$4.58 $4.81 
     


Average Market Metrics  
PLATTS Ethanol price per gallon$1.73 $1.71 
CME Corn cost per bushel$4.38 $4.72 
Board corn crush per gallons (1)$0.17 $0.02 
   
Essential Ingredients Sold (thousand tons)  
Pekin Campus:  
Distillers grains 80.4  90.7 
CO2 43.3  45.3 
Corn wet feed 29.9  34.5 
Corn dry feed 21.0  23.8 
Corn oil and germ 18.1  19.6 
Corn meal 9.5  9.4 
Syrup and other 9.2  8.2 
Yeast 6.1  6.4 
Total Pekin Campus essential ingredients sold 217.5  237.9 
   
Western production:  
Distillers grains 60.1  58.1 
CO2 12.8  12.6 
Corn oil 0.8  1.4 
Syrup and other 0.8  0.8 
Total Western production essential ingredients sold 74.5  72.9 
   
Total Essential Ingredients Sold 292.0  310.8 
   
   
Essential ingredients return % (2)  
Pekin Campus return 54.0% 48.0%
Western production return 49.9% 49.0%
Consolidated total return 53.4% 48.2%
   

________________
            (1)   Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.
            (2)   Essential ingredients revenues as a percentage of total corn costs consumed.


FAQ

What were Alto (ALTO) Q1 2026 earnings per share and net income?

Alto reported net income of $4.0 million, or $0.05 per diluted share. According to the company, this compares to a net loss of $12.0 million in Q1 2025.

How did Alto (ALTO) perform on Adjusted EBITDA in Q1 2026?

Adjusted EBITDA was $4.7 million for Q1 2026. According to the company, this improved by $9.1 million versus negative $4.4 million in Q1 2025.

Did Alto (ALTO) report any one-time or nonoperational items in Q1 2026?

Yes. Q1 2026 results included an $8.1 million unrealized derivative gain and benefits from Section 45Z tax credits. According to the company, these items supported profitability.

What was Alto's (ALTO) cash and liquidity position at March 31, 2026?

Cash and equivalents were $20.3 million, with borrowing availability of $94.3 million. According to the company, availability included $29.3M on the operating line and $65M on the term loan.

Will Alto (ALTO) host an earnings call for Q1 2026 and how to access it?

Yes. Management hosted a conference call on May 6, 2026 at 5:00 PM ET with a webcast. According to the company, the webcast is available on its website and will be archived for one year.